Infant Pneumococcal Vaccine Study

Now Enrolling in Burleson and Houston

Investigational Infant Pneumococcal Vaccine Study

Ventavia Research is seeking new parents for participation in an Investigational Pneumococcal Vaccine Study.

To be eligible for this study, your child must:

  • Be a healthy, full-term infant
  • Be between 42 and 90 days old
  • Have never received a pneumococcal vaccine
  • Have a parent or legal guardian who is able to give informed consent
Trial Enrolling Now

Your baby will soon be exploring the world.

That’s why we’re exploring a new vaccine.

In this study, researchers are testing an investigational pneumococcal vaccine. Pneumococcal disease is any infection caused by bacteria called Streptococcus pneumoniae which causes serious illness, like pneumonia.

The current vaccine options do not prevent all types of pneumococcal infections. Therefore, there is a need for additional research of pneumococcal vaccines.

Interested in signing up?

"*" indicates required fields

This field is for validation purposes and should be left unchanged.